CD40 (TNFRSF5) is a co-stimulatory cell surface receptor expressed in both hematopoietic and non-hematopoietic cells, where it can activate DCs, prime tumor-specific CD8 T cells, and finally stimulate antitumor immunity (36). This evidence concerns the gene CD8A and neoplasm.